Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease

Published:2020-02-06 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Dankers Marloes,Nelissen-Vrancken Marjorie H. J. M. G.,Surminski Sara M. K.,Lambooij Anke C.,Schermer Tjard R.,van Dijk Liset

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Reporting the results of meta-analyses: a plea for incorporating clinical relevance referring to an example;Bartels;Spine J.,2017

2. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research;Beaton;Curr. Opin. Rheumatol.,2002

3. Patient preferences in severe COPD and asthma: a comprehensive literature review;Bereza;Int. J. Chron. Obstruct. Pulmon. Dis.,2015

4. Exacerbation-free time’ to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study;Boer;NPJ Prim. Care Respir. Med.,2018

5. Outcomes for COPD pharmacological trials: from lung function to biomarkers;Cazzola;Eur. Respir. J.,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials;American Journal of Respiratory and Critical Care Medicine;2023-08-15

2. Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals’ preferences;Pharmacology Research & Perspectives;2021-05